Support Muscle Tissue at the Cellular Level

Go to any supplement store and look at the muscle section. You will find protein powders, creatine, BCAAs, and a long list of herbs. All of them work on the building blocks around your muscle cells.

None of them are a peptide bioregulator.

Peptix A-18 with Gotratix is categorically different. It delivers peptide complex A-18 directly to skeletal muscle tissue. One active ingredient. One target tissue. That is the Khavinson framework applied to your muscular system.

✔ Supports healthy skeletal muscle cells and normal muscle tissue function*
✔ Helps maintain normal protein synthesis within muscle tissue*
✔ Supports normal myocyte activity and cellular metabolism*
✔ Formulated with Khavinson peptide complex A-18
✔ Sourced from triceps muscle of young calves using patented filtration technology
✔ 40+ years of published research from the St. Petersburg Institute of Bioregulation and Gerontology

🧬 Why Skeletal Muscle Tissue Function Changes With Age

Skeletal muscle is one of the most metabolically active tissues in the body. It relies on a consistent cycle of protein synthesis to maintain normal function. That cycle depends on tissue-specific peptide signals.

As the body ages, peptide levels in organs and tissues fall. When they do, protein synthesis in those tissues slows. For skeletal muscle, that means the cells that maintain and support normal muscle function become progressively less efficient. This process begins earlier than most people expect.

That age-related cellular decline is what most muscle supplements never address. They provide raw materials. Peptix A-18 with Gotratix goes to the source: the muscle cells themselves.

⚙️ How Gotratix Works — The Cellular Mechanism

Peptix A-18 with Gotratix is a dietary supplement formulated with peptide complex A-18. It is derived from the triceps muscle tissue of young calves using patented filtration technology developed at the St. Petersburg Institute of Bioregulation and Gerontology.

After absorption, the peptides are transported to skeletal muscle tissue via tissue-specific mechanisms. Once there, they act as cellular-level signaling molecules, supporting:

• Healthy activity in skeletal muscle cells and muscle tissue*
• Normal muscle tissue function and myocyte cellular metabolism*
• Normal protein synthesis within skeletal muscle tissue*
• Normal function within the broader physical performance and recovery system*

The mechanism is epigenetic. Based on articles retrieved from PubMed, short peptides bind complementarily to specific nucleotide sequences in DNA strands. That binding reduces the strength of proton bonds in the DNA double helix and stimulates gene transcription and replication. This is how tissue-specific protein synthesis is initiated and maintained at the cellular level. (Khavinson VKh et al. Epigenetic aspects of peptide regulation of aging. Adv Gerontol. 2012;25(1):11-22. PMID: 22708439)

Bryan's Note:

I have spent years going deep on the Khavinson research system. Over 800 peer-reviewed publications. Clinical studies confirmed across 40 years. The St. Petersburg Institute built this science from the ground up starting in the 1970s.

Most people who find peptide bioregulators come in through the longevity angle. They start with the pineal or thymus bioregulators and build from there. What they often miss is that the Khavinson intensive physical activity protocol specifically includes Gotratix A-18. It is in the original grouping alongside Sigumir, Ventfort, Vladonix, and Cerluten for a reason. If you are active and building a complete stack, this is the muscle piece.

That is not marketing. That is how the framework is structured.

Bryan Rider, Founder, Rebel Peptides

🔬 The Research Behind Peptix A-18 with Gotratix

Peptix A-18 with Gotratix belongs to the Khavinson Peptides system. Organ-specific peptide bioregulators developed at the Saint Petersburg Institute of Bioregulation and Gerontology. Dr. Vladimir Khavinson and his team have published over 800 peer-reviewed studies across more than 40 years of research.

Peptide Theory of Aging — Khavinson, 2002
A landmark review in Neuro Endocrinology Letters established the peptide theory of aging: that aging is driven by changes in gene expression resulting in reduced synthesis of tissue-specific peptides in organs and tissues. The proposed correction involves stimulating peptide production or delivering tissue-specific peptides directly. Clinical trials of peptide preparations from multiple organ systems demonstrated improvement in the conditions of respective organs.
Read on PubMed

35 Years of Peptide Bioregulator Research — Khavinson and Anisimov, 2009
A review in Advances in Gerontology summarized 35 years of research on peptide bioregulator mechanisms and clinical efficacy across Russia, the US, the UK, Germany, Italy, Spain, and France. The molecular model described complementary interaction between short peptides and gene promoter sites as the basis for protein biosynthesis initiation. The paper discussed prospects for clinical use of peptide bioregulators in preventing premature aging.
Read on PubMed

Epigenetic Mechanism — Khavinson et al., 2012
Research in Advances in Gerontology confirmed that short endogenous peptides bind complementarily to specific DNA nucleotide sequences. That binding stimulates gene transcription and replication. The paper also described how age-related changes in genome methylation influence site-specific binding of short peptides to DNA, pointing to a direct epigenetic role in the aging process. This mechanism underlies the tissue-specific protein synthesis activity observed across the Khavinson system.
Read on PubMed

Muscle Protein Turnover and Cellular Maintenance — Chang et al., 2025
Research published in Experimental Gerontology confirmed that maintaining positive muscle protein turnover at the cellular level is the primary variable in preserving skeletal muscle mass and function in aging populations. The study highlighted the importance of supporting cellular-level mechanisms rather than only external nutritional inputs.
Read on PubMed

This is peer-reviewed research. Published. Available on PubMed. The science behind Peptix A-18 with Gotratix is documented, not theoretical.

📖 Research Context — For Educational Reference Only

The following describes the research context in which Khavinson skeletal muscle peptides have been studied. It is provided for educational purposes only. Peptix A-18 with Gotratix is a dietary supplement and is not intended to diagnose, treat, cure, or prevent any disease.

Dr. Khavinson's research into skeletal muscle peptide bioregulators was conducted in the context of age-related decline in muscle tissue protein synthesis, as well as support for individuals engaged in intensive physical activity. The research explored how peptide bioregulator supplementation may support the maintenance of normal muscle cell function and protein synthesis in skeletal muscle tissue during aging and physical stress.

None of this constitutes a basis for claiming that Peptix A-18 with Gotratix treats, reduces, or prevents sarcopenia, muscle atrophy, or any other disease or condition. Always consult your doctor before taking this product, especially if you have an existing health concern or take prescription medication.

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

THE ATHLETIC PERFORMANCE AND RECOVERY STACK

Peptix A-18 with Gotratix is the muscle piece of the Khavinson intensive physical activity protocol. It pairs with:

Sigumir A-4 Cartilage Peptide Bioregulator — cartilage and joint tissue support
Ventfort A-3 Blood Vessel Bioregulator — vascular tissue support for circulation

Three tissues. Three tissue-specific peptide complexes. One 30-day course. That is how the Khavinson physical activity protocol was originally structured.

Get all three in the Athletic Performance and Recovery Bundle and save.

Go deeper:
Peptide Bioregulator Stacking Strategies | Khavinson Peptide Bioregulators: Complete List